Literature DB >> 11722424

A comparison of three rapid D-dimer methods for the diagnosis of venous thromboembolism.

M J Kovacs1, K M MacKinnon, D Anderson, K O'Rourke, M Keeney, C Kearon, J Ginsberg, P S Wells.   

Abstract

We compared three rapid D-dimer methods for the diagnosis of venous thromboembolism. Patients presenting to four teaching hospitals with the possible diagnosis of deep vein thrombosis or pulmonary embolism were investigated with a combination of clinical likelihood, D-dimer (SimpliRED) and initial non-invasive testing. Patients were assigned as being positive or negative for deep vein thrombosis or pulmonary embolism based on their three-month outcome and initial test results. The three D-dimer methods compared were: (a) Accuclot D-dimer (b) IL-Test D-dimer (c) SimpliRED D-dimer. Of 993 patients, 141 had objectively confirmed deep vein thrombosis or pulmonary embolism. The sensitivity of SimpliRED, Accuclot and IL-Test were 79, 90 and 87% respectively. All three D-dimer tests gave similar negative predictive values. The SimpliRED D-dimer was found to be less sensitive than the Accuclot or IL-Test. When combined with pre-test probability all three methods are probably acceptable for use in the diagnosis of venous thromboembolism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722424     DOI: 10.1046/j.1365-2141.2001.03060.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

2.  Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings.

Authors:  Suman W Rathbun; Thomas L Whitsett; Sara K Vesely; Gary E Raskob
Journal:  Chest       Date:  2004-03       Impact factor: 9.410

3.  Association between plasma levels of D-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders.

Authors:  Rafael Noal Moresco; Ronald Halla Júnior; Luis Cláudio Rosa Vargas; Lúcia Mariano da Rocha Silla
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

Review 4.  Advances in the diagnosis of venous thromboembolism.

Authors:  Philip S Wells
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

5.  Lack of association between cardiac troponin T and D-dimer in the evaluation of myocardial damage.

Authors:  Rafael Noal Moresco; Luís Cláudio Rosa Vargas; Ronald Halla Júnior; Lúcia Mariano da Rocha Silla
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

Review 6.  D-dimer test for excluding the diagnosis of pulmonary embolism.

Authors:  Fay Crawford; Alina Andras; Karen Welch; Karen Sheares; David Keeling; Francesca M Chappell
Journal:  Cochrane Database Syst Rev       Date:  2016-08-05

Review 7.  Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review.

Authors:  Tonya L Fancher; Richard H White; Richard L Kravitz
Journal:  BMJ       Date:  2004-09-21

8.  D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems.

Authors:  Rafael Noal Moresco; Luis Cláudio Rosa Vargas; Carlos Franco Voegeli; Roberto Christ Vianna Santos
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

9.  Estimation of the levels of D-dimer by use of an alternative method based in the reaction time of fibrinogen/fibrin degradation products assay.

Authors:  Rafael Noal Moresco; Luis Cláudio Rosa Vargas; Lúcia Silla
Journal:  J Thromb Thrombolysis       Date:  2006-12-09       Impact factor: 5.221

10.  Diagnostic Value of D-Dimer's Serum Level in Iranian Patients with Cerebral Venous Thrombosis.

Authors:  Leila Hashami; Vahid Rakhshan; Hoda Karimian; Mehdi Moghaddasi
Journal:  Neurol Int       Date:  2016-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.